Arcus Biosciences (RCUS) PT Raised to $48 at Wedbush, Following Important Business Update
Tweet Send to a Friend
Wedbush analyst Robert Driscoll raised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
